Control Batch, Quality, and Clinical Execution Across Regulated Systems
BCS connects batch manufacturing, quality management, pharmacovigilance, and regulatory systems into a governed execution layer — accelerating batch release, reducing CAPA cycle times, and maintaining continuous compliance across regulated operations.
Built for Life Sciences Leaders
What Life Sciences Executives Are Prioritising Right Now
- Accelerating batch release without compromising quality controls
- Closing deviation and CAPA cycles faster across manufacturing sites
- Maintaining continuous audit readiness across regulated systems
- Reducing time-to-market through coordinated regulatory submission workflows
- Strengthening pharmacovigilance and safety reporting across global operations
The Operating Problem
Where Regulated Execution Slows Down
-
Disconnected batch and quality systems
Manufacturing execution, laboratory, and ERP systems operate in isolation. Batch record review, quality checks, and release approvals require manual coordination, slowing cycle times and creating compliance gaps.
-
Slow deviation and CAPA resolution
Deviation events, investigations, and corrective actions are tracked across disconnected systems. Root cause analysis and closure are delayed, extending batch holds and increasing regulatory exposure.
-
Fragmented pharmacovigilance workflows
Safety data from clinical, post-market, and partner sources is collected and reviewed across separate systems. Case processing and regulatory reporting timelines are at risk when coordination fails.
-
Identity and access governance gaps
Access to validated systems and regulated data lacks continuous enforcement. Unresolved access conflicts and manual review cycles create audit findings and expose organisations to 21 CFR Part 11 and EU GMP Annex 11 non-compliance.
-
Uncoordinated product launch and regulatory readiness
Regulatory approvals, supply readiness, and commercial preparation are managed across separate teams and systems. Misalignment delays launches and creates last-minute compliance escalations.
How BCS Works
Move From Fragmented Operations to Governed Execution
BCS connects life sciences manufacturing, quality, safety, and regulatory systems into a single governed execution model. Five structured steps take you from fragmented operations to continuous, audit-ready control.
Map Your Regulated System Landscape
BCS begins with a structured assessment of your manufacturing, quality, safety, and regulatory system environment. Integration gaps, compliance risks, and coordination bottlenecks are identified across every system boundary — creating the foundation for a governed execution model built around your existing platforms.
Unify Manufacturing, Quality, Safety, and Commercial Systems
BCS establishes a governed connection layer across your existing MES, LIMS, ERP, and safety platforms. Manufacturing execution, quality governance, safety workflows, and commercial readiness operate under a single orchestration model — eliminating the manual handoffs that slow batch release and compliance cycles.
Automate Batch, Quality, and Safety Workflows
BCS routes batch events, deviation triggers, and safety notifications through automated, governed workflows. Batch processing, quality event management, and safety reporting run in parallel tracks orchestrated by a single execution engine — eliminating the manual coordination that extends cycle times and creates compliance gaps.
Enforce Continuous Access and Compliance Controls
BCS enforces role-based access across validated manufacturing, laboratory, and enterprise systems continuously. Segregation-of-duties conflicts are resolved automatically, privileged access reviews run on schedule, and every access decision generates a complete audit trail — keeping your environment inspection-ready at all times.
Validate Performance Across Every Regulated Dimension
deKorvai continuously monitors batch release KPIs, quality event metrics, and regulatory compliance scores across all connected systems. Performance data is validated in real time, giving operations, quality, and regulatory teams a single source of truth for continuous improvement and inspection readiness.
Move Faster Without Execution Risk
A structured approach maps your manufacturing, quality, safety, and regulatory system landscape — enabling transition to a governed, agentic life sciences execution model without disrupting validated operations.
Why Choose BCS
Built for Regulated Life Sciences Operations
Life sciences enterprises face an execution challenge that is distinct from other industries: every workflow must meet regulatory requirements while still operating at commercial speed. BCS connects manufacturing, quality, safety, and regulatory systems into a governed execution model that enforces compliance, eliminates coordination gaps, and delivers consistent outcomes across every regulated process.
Unified Batch and Quality Execution Layer
Connects manufacturing execution, laboratory, and core ERP systems into a single coordinated release flow. Batch record review, quality checks, and release approvals run as a continuous process, eliminating manual handoffs and reducing cycle time from days to hours.
Automated Deviation and CAPA Resolution
Routes deviation events, investigation tasks, and corrective actions through governed workflows automatically. Root cause analysis timelines are enforced and closure actions are tracked across systems, reducing batch hold duration and regulatory exposure.
Coordinated Pharmacovigilance Workflows
Aggregates safety data from clinical, post-market, and partner sources into a single governed processing flow. Case validation, medical review, and regulatory reporting run on schedule without manual coordination between safety teams and systems.
Continuous Access Governance for Validated Systems
Enforces role-based access across validated manufacturing, laboratory, and enterprise applications continuously. Segregation-of-duties conflicts are resolved automatically and privileged access reviews complete on schedule, maintaining 21 CFR Part 11 and EU GMP Annex 11 readiness without manual cycles.
Coordinated Product Launch and Regulatory Readiness
Aligns regulatory approvals, supply readiness, and commercial preparation across teams and systems under a single orchestration model. Launch dependencies are tracked continuously, reducing last-minute escalations and improving time-to-market predictability.
One Governed Operating Model for Regulated Execution
Aligns manufacturing, quality, safety, and regulatory workflows under a single execution model. Every batch decision, quality event, safety case, and access change is controlled, traceable, and consistent across every facility and regulated system in the enterprise.
Life sciences enterprises do not need to replace existing validated systems to restore operational control. BCS connects the manufacturing, quality, safety, and regulatory systems already in use into a governed execution model that enforces compliance, eliminates coordination gaps, and delivers consistent outcomes across every regulated workflow.
Use Cases
Governed Execution Across Regulated Life Sciences Operations
From batch release and deviation management to pharmacovigilance and product launch — governed workflows that deliver compliance, control, and traceability across every regulated process.
Manufacturing · Quality Release
Automated Batch Record Review and Release
When batch records, lab results, and ERP release approvals live in separate systems, manual reconciliation becomes the handoff between manufacturing and disposition. Teams spend release cycles gathering and cross-checking data rather than executing. Each manual step adds time, introduces transcription risk, and creates audit gaps that surface at inspection.
Quality Management · Compliance
Deviation Detection and CAPA Workflow Automation
Quality deviations in regulated manufacturing require coordinated investigation, root cause analysis, and corrective action across systems and teams. Without enforced routing and closure tracking, investigation timelines slip, tasks fall between system boundaries, and repeat events accumulate. Each unresolved CAPA cycle increases exposure at the next regulatory inspection.
Safety · Regulatory Reporting
Automated Safety Case Processing and Regulatory Submission
Adverse event data enters life sciences organisations through clinical trials, post-market surveillance, and partner channels simultaneously. Without a governed intake and routing model, case processing depends on manual handoffs between safety science, medical review, and regulatory affairs. Submission deadlines are missed when data completeness gaps are discovered late in the workflow.
Identity Governance · Validated Systems
Continuous Access Control Across Regulated Platforms
In regulated environments, access control is both a security control and a compliance obligation. User provisioning, segregation-of-duties enforcement, and periodic access recertification across validated systems generate audit requirements that manual review processes cannot consistently meet. Access gaps identified at inspection carry significant remediation cost and regulatory risk.
Commercial · Regulatory Coordination
Coordinated Product Launch and Regulatory Readiness
Product launches in life sciences require regulatory approval, commercial readiness, and supply availability to converge on a single date. When these workstreams are tracked across disconnected systems, schedule misalignments surface late, escalation paths are informal, and launch-critical tasks lack cross-functional visibility until the timeline is already under pressure.
Contact Us
Ready to Govern Your Regulated Life Sciences Operations
Speak with a BCS life sciences specialist. We'll map your current manufacturing, quality, safety, and regulatory system landscape, identify the highest-impact orchestration gaps, and outline a path to governed, agentic life sciences execution.